Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Acelyrin makes a splash with IPO, biopharma expects to raise $540M
Medical Marketing and Media
Sun, 05/7/23 - 10:16 pm
Acelyrin
IPOs
Acelyrin follows Kenvue with largest IPO for a biotech startup since 2021
BioPharma Dive
Fri, 05/5/23 - 12:08 pm
Acelyrin
IPOs
Kenvue
J&J sets top price for consumer health unit Kenvue’s IPO
Pharmaphorum
Thu, 05/4/23 - 09:57 am
JNJ
spinoff
Kenvue
IPOs
consumer health
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
CNBC
Tue, 04/25/23 - 10:44 am
JNJ
consumer health
IPOs
Kenvue
spinoffs
IPO Market Shows Signs of Life as Acelyrin Begins Nasdaq Bid
BioSpace
Sun, 04/16/23 - 11:10 pm
Acelyrin
IPOs
immunology
After a record run, fewer biotechs are going public. Here’s how they’re performing.
BioPharma Dive
Fri, 04/14/23 - 10:21 am
biotech
IPOs
Floating biotechs prompt tiny sparks of hope
EP Vantage
Mon, 04/10/23 - 11:16 am
IPOs
biotech
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
BioXcel takes surprising path with IPO of oncology spinout OnkosXcel
Fierce Biotech
Wed, 03/15/23 - 09:37 pm
BioXcel
IPOs
oncology
OnkosXcel
IPOs vs SPACs
EP Vantage
Thu, 03/9/23 - 09:47 am
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
A small Connecticut biotech throws hat into IPO ring
Endpoints
Tue, 02/21/23 - 04:28 pm
Azitra
IPOs
skin diseases
dermatology
IPO Doors Creak Open as Mineralys Seeks $192M
BioSpace
Fri, 02/10/23 - 10:31 am
IPOs
Mineralys Therapeutics
hypertension
MLS-101
Swiss rare disease biotech withdraws IPO to update its Nasdaq plans
Endpoints
Wed, 02/8/23 - 10:30 am
Relief Therapeutics
IPOs
Biotech startup Structure pulls off rare IPO, raising $161M
BioPharma Dive
Fri, 02/3/23 - 10:34 am
IPOs
Structure Therapeutics
Biotech CFOs eye research cuts, partnerships amid sector retrenchment: report
BioPharma Dive
Mon, 01/30/23 - 10:52 am
biotech
CFOs
R&D
funding
IPOs
Mineralys polishes $100M IPO plans ahead of phase 3 in hypertension
Fierce Biotech
Thu, 01/19/23 - 09:59 am
IPOs
Mineralys
hypertension
5 questions facing emerging biotech in 2023
BioPharma Dive
Tue, 01/10/23 - 06:44 pm
biotech
IPOs
platform companies
funding
restructuring
Inflation Reduction Act
Ready for takeoff: J&J's consumer health unit Kenvue files for official separation
Endpoints
Thu, 01/5/23 - 05:02 pm
JNJ
IPOs
consumer health
Kenvue
spinoffs
IPOs fail to bounce back in Q4
EP Vantage
Thu, 01/5/23 - 10:16 am
IPOs
Prime Medicine
Acrivon Therapeutics
Lipella Pharmaceuticals
Disappearing IPOs, building startups and closing deals: Views from an up-and-down year in biotech
BioPharma Dive
Tue, 01/3/23 - 10:03 am
IPOs
venture capital
funding
Health tech companies weigh funding options amid weak IPO market
BioPharma Dive
Tue, 11/22/22 - 11:06 am
Medtech
IPOs
pandemic
inflattion
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »